New training aims to give veterans with mental illness a stronger voice in their care
NCT ID NCT04324944
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a program called Collaborative Decision Skills Training (CDST) to help veterans with serious mental illness (like schizophrenia or major depression with psychosis) work more closely with their doctors in making treatment decisions. The program involved eight weekly group sessions. Researchers measured how often veterans spoke up and shared decisions with their providers. The goal was to see if the training was practical and helpful, and to gather information for larger future studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
39 people
The number who actually took part.
- Started
-
Jul 2022
- Finished
-
Sep 2025
- Lead sponsor
-
A government agency
The lead sponsor is a US federal agency other than the NIH.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * currently receive services in the VASDHS PRRC * i.e., seen in the clinic in the past month and/or completed a PRRC group during the past trimester * have an SMI diagnosis per the electronic medical record * e.g., schizophrenia, schizoaffective disorder, delusional disorder, and major depressive disorder with psychotic features * agree to have a subset of treatment appointments audiotaped Exclusion Criteria: * having primary substance use or organic neurological disorder diagnosis * are determined by PRRC and/or study staff to be at significant risk of exacerbation of symptoms, suicidal ideation, or other risk due to study participation * have a history and/or current risk of violence that PRRC and/or study staff determine to be too high risk to manage effectively at the PRRC's outpatient clinic location (which has less police presence than the primary VASDHS hospital location)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Delusional disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
VA San Diego Healthcare System, San Diego, CA
San Diego, California, 92161-0002, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists probe brain's reward system in mental illness
- New schizophrenia drug targets brain glutamate, not dopamine
- New drug candidate takes aim at schizophrenia symptoms
- New schizophrenia drug goes Head-to-Head with standard antipsychotics in Long-Term trial
- Five-Year safety check for experimental schizophrenia drug
- A shot every few weeks? new drug tested for schizophrenia